Evidence map›Paper›PMID 20605978›Full record

ArticleInfection and immunity2010

The lung is an important site for priming CD4 T-cell-mediated protective immunity against gastrointestinal helminth parasites.

Marina Harvie, Mali Camberis, Shiau-Choot Tang, Brett Delahunt, William Paul, Graham Le Gros

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 105 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. CD8Nature communications · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Basophils in antihelminth immunity.Seminars in immunology · 2021
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Marina HarvieMalaghan Institute of Medical Research, P.O. Box 7060, Wellington 6242, New Zealand.
Mali Camberis
Shiau-Choot Tang
Brett Delahunt
William Paul
Graham Le Gros
Malaghan Institute of Medical Research · NZNational Institute of Allergy and Infectious Diseases · US

Funding

Interleukin 4ZIAAI000493 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI GERMAIN, RONALD N · 2009 to 2017
$11.5M
INTERLEUKIN 4 (IL-4)Z01AI000493 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI PAUL, WILLIAM · 1987 to 2008
$3.1M
Intramural NIH HHS Z01 AI000493
6 · The paper itself

Abstract

The rodent hookworm Nippostrongylus brasiliensis typically infects its host by penetrating the skin and rapidly migrating to the lungs and gut. Following primary infection, immunocompetent mice become highly protected from reinfection with N. brasiliensis, with the numbers of worms gaining access to the lungs and gut being reduced by up to 90%. We used green fluorescent protein/interleukin-4 (IL-4) reporter mice and truncated infection studies to identify both the tissue site and mechanism(s) by which the host protects itself from reinfection with N. brasiliensis. Strikingly, we demonstrated that the lung is an important site for priming immune protection. Furthermore, a lung-initiated, CD4 T-cell-dependent, and IL-4- and STAT6-dependent response was sufficient to confer protection against reinfection. In conclusion, vaccination strategies which seek to break the cycle of reinfection and egg production by helminths such as hookworms can include strategies which directly stimulate Th2 responses in the lung.

Indexed as

NippostrongylusAnimalsAntibodies, HelminthCD4-Positive T-LymphocytesCytokinesIntestinal Diseases, ParasiticLungMiceMice, Inbred BALB CMice, Inbred C57BLRecurrenceSkinStrongylida InfectionsTh2 CellsAntibodies, HelminthCytokines

Identifiers

PMID20605978
PMCPMC2937440
OpenAlexW2114054468

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.